Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

973 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An oncological view on the blood-testis barrier.
Bart J, Groen HJ, van der Graaf WT, Hollema H, Hendrikse NH, Vaalburg W, Sleijfer DT, de Vries EG. Bart J, et al. Among authors: de vries eg. Lancet Oncol. 2002 Jun;3(6):357-63. doi: 10.1016/s1470-2045(02)00776-3. Lancet Oncol. 2002. PMID: 12107023 Review.
Experimental animal model for anthracycline-induced heart failure.
Perik PJ, van den Berg MP, de Vries EG, van Veldhuisen DJ. Perik PJ, et al. Among authors: de vries eg. Eur J Heart Fail. 2004 Jun;6(4):375-6. doi: 10.1016/j.ejheart.2003.12.017. Eur J Heart Fail. 2004. PMID: 15182760 Free article. No abstract available.
Preclinical characterisation of 111In-DTPA-trastuzumab.
Lub-de Hooge MN, Kosterink JG, Perik PJ, Nijnuis H, Tran L, Bart J, Suurmeijer AJ, de Jong S, Jager PL, de Vries EG. Lub-de Hooge MN, et al. Among authors: de vries eg, de jong s. Br J Pharmacol. 2004 Sep;143(1):99-106. doi: 10.1038/sj.bjp.0705915. Epub 2004 Aug 2. Br J Pharmacol. 2004. PMID: 15289297 Free PMC article.
The dilemma of the strive for apoptosis in oncology: mind the heart.
Perik PJ, de Vries EG, Gietema JA, van der Graaf WT, Sleijfer DT, Suurmeijer AJ, van Veldhuisen DJ. Perik PJ, et al. Among authors: de vries eg. Crit Rev Oncol Hematol. 2005 Feb;53(2):101-13. doi: 10.1016/j.critrevonc.2004.10.001. Crit Rev Oncol Hematol. 2005. PMID: 15661561 Review.
Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer.
Hoekstra R, de Vos FY, Eskens FA, Gietema JA, van der Gaast A, Groen HJ, Knight RA, Carr RA, Humerickhouse RA, Verweij J, de Vries EG. Hoekstra R, et al. Among authors: de vries eg, de vos fy. J Clin Oncol. 2005 Aug 1;23(22):5188-97. doi: 10.1200/JCO.2005.05.013. J Clin Oncol. 2005. PMID: 16051960 Clinical Trial.
Fatigue and relating factors in high-risk breast cancer patients treated with adjuvant standard or high-dose chemotherapy: a longitudinal study.
Nieboer P, Buijs C, Rodenhuis S, Seynaeve C, Beex LV, van der Wall E, Richel DJ, Nooij MA, Voest EE, Hupperets P, Mulder NH, van der Graaf WT, TenVergert EM, van Tinteren H, de Vries EG. Nieboer P, et al. Among authors: de vries eg. J Clin Oncol. 2005 Nov 20;23(33):8296-304. doi: 10.1200/JCO.2005.10.167. Epub 2005 Oct 11. J Clin Oncol. 2005. PMID: 16219926 Clinical Trial.
Hot flushes in breast cancer patients.
Mom CH, Buijs C, Willemse PH, Mourits MJ, de Vries EG. Mom CH, et al. Among authors: de vries eg. Crit Rev Oncol Hematol. 2006 Jan;57(1):63-77. doi: 10.1016/j.critrevonc.2005.04.009. Crit Rev Oncol Hematol. 2006. PMID: 16343926 Review.
973 results